Increlex

Severe primary IGFD is an endocrine disorder that impairs growth in children. Our campaign features children, at first restricted by the flowers that surround them, finally breaking free to grow and blossom, serving as a metaphor for the restrictions placed on human growth when IGF-1 is deficient. Tercica partnered with us to create this memorable and relevant campaign for Increlex^® (mecasermin [rDNA origin] injection). The campaign is still one of the most recognized in the endocrinology market.